BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35142436)

  • 1. The value of next-generation sequencing in routine diagnostics and management of patients with cytopenia.
    Breinholt MF; Nielsen K; Schejbel L; Fassi DE; Schöllkopf C; Novotny GW; Mortensen BK; Ahmad A; Høgdall E; Nørgaard P
    Int J Lab Hematol; 2022 Jun; 44(3):531-537. PubMed ID: 35142436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic and prognostic role of flow cytometry in idiopathic and clonal cytopenia of undetermined significance (ICUS/CCUS): A single-center analysis of 79 patients.
    Dimopoulos K; Hansen OK; Sjö LD; Saft L; Schjødt IM; Werner Hansen J; Grønbaek K
    Cytometry B Clin Cytom; 2020 May; 98(3):250-258. PubMed ID: 31479199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications and genetic features of clonal cytopenia of undetermined significance compared to lower-risk myelodysplastic syndrome.
    Choi EJ; Cho YU; Hur EH; Park HS; Choi Y; Lee JH; Lee KH; Kim M; Hwang SH; Jang S; Park CJ; Seo EJ; Lee JH
    Br J Haematol; 2022 Aug; 198(4):703-712. PubMed ID: 35612271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted NGS on sequential bone marrow biopsies aids in the evaluation of cytopenias and monocytosis and documents clonal evolution-a proof of principle study.
    Nann D; Rau A; Mahmutovic L; Steinhilber J; Meca V; Federmann B; Vogel W; Bonzheim I; Quintanilla-Martinez L; Fend F
    Virchows Arch; 2023 Dec; 483(6):835-845. PubMed ID: 37610626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Lower Frequency of Spliceosome Mutations Distinguishes Clonal Cytopenias of Undetermined Significance From Low-Risk Myelodysplastic Syndromes, Despite Inherent Similarities in Genomic, Laboratory, and Clinical Features.
    Ferrone CK; McNaughton AJM; Rashedi I; Ring B; Buckstein R; Tsui H; Rauh MJ
    Mod Pathol; 2023 Mar; 36(3):100068. PubMed ID: 36788103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of next-generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndrome.
    Kawata E; Lazo-Langner A; Xenocostas A; Hsia CC; Howson-Jan K; Deotare U; Saini L; Yang P; Broadbent R; Levy M; Howlett C; Stuart A; Kerkhof J; Santos S; Lin H; Sadikovic B; Chin-Yee I
    Br J Haematol; 2021 Feb; 192(4):729-736. PubMed ID: 32588428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic utility of targeted gene panel sequencing in discriminating etiologies of cytopenia.
    Zheng G; Chen P; Pallavajjalla A; Haley L; Gondek L; Dezern A; Ling H; De Marchi F; Lin MT; Gocke C
    Am J Hematol; 2019 Oct; 94(10):1141-1148. PubMed ID: 31350794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia.
    Jajosky AN; Sadri N; Meyerson HJ; Oduro KA; Kelkar A; Fitzgerald B; Tomlinson B; Moore EM; Beck RC
    Eur J Haematol; 2021 Apr; 106(4):500-507. PubMed ID: 33386622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexplained chronic cytopenia: is it idiopathic cytopenia of undetermined significance or myelodysplastic syndrome.
    Ramachandran P; Erdinc B; Sahni S; Avezbakiyev B
    BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31630129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.
    Polprasert C; Niparuck P; Rattanathammethee T; Chuncharunee S; Kobbuaklee S; Songserm K; Suksusut A; Trithiphen S; Lanamtieng T; Kongkiatkamon S; Chanswangphuwana C; Lawasut P; Bunworasate U; Rojnuckarin P
    Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):e293-e299. PubMed ID: 34840089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort.
    Diral E; Campochiaro C; Tomelleri A; Bergonzi GM; Pizzano U; Ponzoni M; Bongiovanni L; Ronchi P; Tresoldi C; Rigamonti S; Scarfò F; Latino GM; Rinaldi E; Bernardi M; Dagna L; Ciceri F
    Front Immunol; 2024; 15():1354130. PubMed ID: 38333211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group.
    Hebeda KM; Tzankov A; Boudova L; Saft L; Hasserjian RP; de Boer M; Fend F; Orazi A; Leguit R
    Pathobiology; 2019; 86(1):62-75. PubMed ID: 29982244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of Targeted Sequencing Assay for Patients with Suspected Myeloid Malignancies].
    Zhang LJ; Shi YY; Chen Y; Deng Y; Ding YH; Li Z; Chen KK; Ding BH; Wang CL; Yu L; He ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1985-1990. PubMed ID: 33283730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm.
    Ibrar W; Zhang W; Cox JL; Cushman-Vokoun A; Fu K; Greiner TC; Yuan J
    Int J Lab Hematol; 2021 Dec; 43(6):1501-1509. PubMed ID: 34270867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A predictive model for bone marrow disease in cytopenia based on noninvasive procedures.
    Træden D; Tulstrup M; Cowland JB; Sjö LD; Bøgsted M; Grønbæk K; Andersen MK; Hansen JW
    Blood Adv; 2022 Jun; 6(11):3541-3550. PubMed ID: 35427424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive analysis of cytopenias and bone marrow morphology in patients with a history of bariatric and metabolic surgery.
    Bruehl FK; Bosler DS; Butsch WS; Farkas DH; Ondrejka SL
    Int J Lab Hematol; 2022 Apr; 44(2):263-272. PubMed ID: 34668320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How I investigate Clonal cytogenetic abnormalities of undetermined significance.
    Tang G; Medeiros LJ; Wang SA
    Int J Lab Hematol; 2018 Aug; 40(4):385-391. PubMed ID: 29624895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic analysis of Chinese patients with clonal cytopenias using targeted next-generation sequencing.
    Zhang L; Shi Y; Chen Y; Tao S; Shi W; He Z; Chen K; Wang C; Yu L
    Mol Cytogenet; 2021 Nov; 14(1):52. PubMed ID: 34794475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICUS/CCUS/CHIP: basics & beyond.
    Jain M; Tripathi A
    Expert Rev Hematol; 2017 Oct; 10(10):915-920. PubMed ID: 28832236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.